FEXOPOZAT

This brand name is authorized in Nigeria.

Active ingredients

The drug FEXOPOZAT contains one active pharmaceutical ingredient (API):

1	Cefuroxime UNII O1R9FJ93ED - CEFUROXIME
	Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.
	Read more about Cefuroxime

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0374	Injection	FEXOPOZAT INJECTION INJ 750 mg 1 X 1VIAL	FEXOPOZAT INJECTION FEXOPOZAT CEFUROXIME 750MG POM INJECTION 1 X 1VIAL ANTIBIOTIC FEXONA PHARM CO. LIMITED 19, AKINLAWON STREET, IJESHA-SURULERE, LAGOS STATE NCPC HEBEI HUAMIN PHARMA CO. LIMITED NO 98, HAINAN ROAD, ECONOMIC & TECHNOLOGICAL DEVELOPMENT ZONE, SHIIJIAZHUANG, CHINA. GMP- SATIS; LR- SATIS; FEES- PAID; NP:NA 06/07/2018 C4-0374	30/01/2020
C4-1990	Tablet	Fexopozat 500 Tablets TAB 500 mg 1 X 10	Fexopozat 500 Tablets C4-1990 Fexopozat CEFUROXIME AXETIL PRESCRIPTION ONLY MEDICINE ANTIBIOTIC CEFUROXIME AXETIL 500MG TABLET 1 X 10 TREATMENT OF SUSCEPTIBLE INFECTIONS FEXONA PHARM CO LTD NIGERIA ZEE LABORATORIES LTD INDIA 05/26/2022 05/25/2027	26/05/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DC02	Cefuroxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0374, C4-1990